H2-receptor antagonists in the treatment of functional (nonulcer) dyspepsia:: a meta-analysis of randomized controlled clinical trials

被引:43
作者
Redstone, HA
Barrowman, N
van Zanten, SJO
机构
[1] Dalhousie Univ, Div Gastroenterol, Halifax, NS, Canada
[2] Thomas Chalmers Ctr Systemat Review, Ottawa, ON, Canada
关键词
D O I
10.1046/j.1365-2036.2001.01044.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aim: To perform a meta-analysis evaluating the efficacy of H-2-receptor antagonists in functional (nonulcer) dyspepsia. Selection of studies: A Medline search was used to identify placebo controlled randomized clinical trials, using the subject headings dyspepsia and H-2-receptor antagonist. Outcome measures: Global assessment by the patient of dyspepsia symptoms, improvement of epigastric pain and complete relief of epigastric pain. Results: Twenty-two studies met the inclusion criteria, 15 of which reported the active drug to be superior to placebo. Many studies suffered from suboptimal study design, The odds ratio in favour of active drug was 1.48 (95% confidence interval: 0.9-2.3) for global assessment of dyspepsia symptoms, 2.3 (95% CI: 1.6-3.3) for improvement of epigastric pain, and 1.8 (95% CI: 1.2-2.8) for complete relief of epigastric pain. Conclusion: There is some evidence that H2-receptor antagonists are superior to placebo in functional dyspepsia, but larger studies evaluating higher doses of H-2-receptor antagonists and of longer duration are necessary to determine the exact effect size.
引用
收藏
页码:1291 / 1299
页数:9
相关论文
共 40 条
[21]   A CONTROLLED TRIAL OF CIMETIDINE FOR THE TREATMENT OF NONULCER DYSPEPSIA [J].
LANCE, P ;
WASTELL, C ;
SCHILLER, KFR .
JOURNAL OF CLINICAL GASTROENTEROLOGY, 1986, 8 (04) :414-418
[22]   THE MULTI-CROSSOVER MODEL FOR CLASSIFYING PATIENTS AS RESPONDERS TO A GIVEN TREATMENT [J].
LARSEN, S ;
FARUP, P ;
FLATEN, O ;
OSNES, M .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1991, 26 (07) :763-770
[23]   CIMETIDINE IN THE MANAGEMENT OF SYMPTOMATIC PATIENTS WITH DUODENITIS - A DOUBLE-BLIND CONTROLLED TRIAL [J].
MACKINNON, M ;
WILLING, RL ;
WHITEHEAD, R .
DIGESTIVE DISEASES AND SCIENCES, 1982, 27 (03) :217-219
[24]  
MULLER P, 1994, ARZNEIMITTEL-FORSCH, V44-2, P1130
[25]   EFFECT OF CIMETIDINE IN PATIENTS WITH NON-ULCER DYSPEPSIA AND EROSIVE PREPYLORIC CHANGES [J].
NESLAND, A ;
BERSTAD, A .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1985, 20 (05) :629-635
[26]   ABSENCE OF THERAPEUTIC BENEFIT FROM ANTACIDS OR CIMETIDINE IN NONULCER DYSPEPSIA [J].
NYREN, O ;
ADAMI, HO ;
BATES, S ;
BERGSTROM, R ;
GUSTAVSSON, S ;
LOOF, L ;
NYBERG, A .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (06) :339-343
[27]  
Nyren O, 1992, Pharmacoeconomics, V1, P312
[28]  
Olubuyide I O, 1986, Scand J Gastroenterol Suppl, V124, P83, DOI 10.3109/00365528609093787
[29]   THERAPEUTIC RESPONSE AS A DIAGNOSTIC-TOOL [J].
PETERSEN, H ;
LOGE, I ;
JOHANNESSEN, T ;
FJOSNE, U ;
KLEVELAND, PM ;
KRISTENSEN, P ;
SANDBAKKEN, P ;
HAFSTAD, PE ;
HALVORSEN, T .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1987, 22 :108-113
[30]   CONTROLLED TRIALS IN GASTRO-DYSPEPSIA - A METHODOLOGICAL ASPECT [J].
PETERSEN, H ;
LARSEN, S ;
SANDVIK, L ;
KLEVELAND, PM ;
LOGE, I ;
SANDBAKKEN, P ;
HAFSTAD, PE ;
KRISTENSEN, P ;
JOHANNESSEN, T ;
FJOSNE, U .
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1985, 20 :153-158